An active role for patients in clinical research?

Drug Development Research

Volumn 67, Issue 3, 2006, Pages 188-192

  O'Connell, Deirdre ^a,d   Mosconi, Paola ^b,c  

^a Forum Ireland   (Ireland)

^b EUROPA DONNA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d NONE   (Ireland)

Author keywords

Clinical research; Empowerment; Patient's participation

Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG;

BREAST CANCER; CANCER RESEARCH; CLINICAL RESEARCH; CONSUMER; DOCTOR PATIENT RELATION; EMPOWERMENT; FOOD AND DRUG ADMINISTRATION; HORMONE SUBSTITUTION; HUMAN; INFORMED CONSENT; OUTCOMES RESEARCH; PATIENT ADVOCACY; PATIENT EDUCATION; PATIENT PARTICIPATION; QUALITY OF LIFE; REVIEW;

EID: 33746265436     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20076     Document Type: Review

References (13)

1. Apolone G. 2003. Clinical and outcome research in oncology. The need for integration. Health QOL Outcomes 1:3.
2. Dazzi D, Agnetti B, Bandini L. 2001. What do the people think (and know) about informed consent for participation in a medical trial. Arch Intern Med 161:768-769.
3. Ellis PM, Dowsett SM, Butow PN, Tattersall MH. 1999. Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect 2:33-43.
4. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Honssami N. 2001. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol 19: 3554-3561.
5. EMEA. 2005. Annual Report for 2004. EMEA/61492/2005/EN/FinalEMEA 2005 Page 20/130.
6. Featherstone K, Donovan JL. 2002. Why don't they just tell me straight, why allocate it? The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med 55:709-719.
7. Hanley B, Truesdale A, King A, Elbourne D, Chalmers. 2001. I Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. Br Med J 322:519-523.
8. Holmberg L, Anderson H HABITS steering and data monitoring committees. 2004. HABITS (hormonal replacement therapy after breast cancer; is it safe?), a randomised comparison; trial stopped. Lancet 363:453-455.
9. Marsden J, Bradburn J. 2004. Patient and clinician collaboration in the design of a national randomized breast cancer trial. Health Expect 7:6-17.
10. Mosconi P, Colombo C, Labianca R, Apolone G. 2006. Oncologists' opinions about research ethics committees in Italy: an update, 2004. Eur J Cancer Prevention 15:91-94.
11. Mosconi P, Poli P, Giolo A, Apolone G. 2005. How health consumers feel about clinical research: a questionnaire survey. Eur J Public Health 15:372-379.
12. Moynihan R, Heath I, Henry D. 2002. Selling sickness: the pharmaceutical industry and disease mongering. Br Med J 324: 886-891.
13. NBCC. 2003. Position Statement on Breast Cancer Advocate Involvement in the Research Process. April 2003. http://www.stopbreastcancer.org